This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel drug candidates. It serves as a key intermediate in the creation of compounds targeting central nervous system disorders, such as anxiety, depression, and neurodegenerative diseases. Its pyrrolidine and pyrazole moieties make it a versatile building block for designing molecules with potential receptor-binding activity. Additionally, it is explored in the development of selective enzyme inhibitors, which are crucial for treating various metabolic and inflammatory conditions. Its dihydrochloride form enhances solubility, making it suitable for in vitro and in vivo studies during preclinical drug discovery phases.